Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 3/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | MAOA | P21397 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29539979 | 1.00 | TTR (0.58) | TTRAKR1B1NPC1RAB9AMAOA | |
| SCHEMBL11485002 | 0.90 | MMP12 (0.52) | AKR1B1NPC1RAB9AKDM4EALDH1A1 | |
| Ketoprofen SCHEMBL30621352 | 0.89 | MAPT (0.64) | TTRAKR1B1NPC1RAB9AMAOA | |
| Ketoprofen SCHEMBL29098371 | 0.89 | MAPT (0.64) | TTRAKR1B1NPC1RAB9AMAOA | |
| SCHEMBL28408765 | 0.87 | AKR1B1 (0.46) | TTRAKR1B1NPC1RAB9AMAOA | |
| SCHEMBL29996199 | 0.87 | AKR1B1 (0.46) | TTRAKR1B1NPC1RAB9AMAOA | |
| SCHEMBL25750572 | 0.85 | NPC1 (0.53) | TTRAKR1B1NPC1RAB9AMAOA | |
| SCHEMBL18412610 | 0.85 | MAOA (0.55) | TTRNPC1RAB9AMAOAKDM4E | |
| SCHEMBL11434643 | 0.84 | AKR1B1 (0.55) | TTRAKR1B1NPC1RAB9AKDM4E | |
| SCHEMBL4426956 | 0.83 | MAOA (0.60) | TTRNPC1RAB9AMAOAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11623975-B2 | Molding material and method for producing resin molded body using same | OSAKA UNIVERSITY (JP) | 2023-04-11 | — | — | US | claimed |
| WO-2020244992-A1 | RADIATION-CURABLE COMPOSITION BY ANIONIC POLYMERIZATION | HENKEL AG & CO. KGAA (DE) | 2020-12-10 | — | — | WO | claimed |
| CN-109280160-B | Method for preparing polycarbonate by ionic liquid catalysis | 中国科学院过程工程研究所 | 2020-10-27 | — | — | CN | claimed |
| US-12637573-B2 | Antifouling coating composition | CHUGOKU MARINE PAINTS, LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| WO-2026105358-A1 | SEMICONDUCTIVE MEMBER, STATOR COIL, AND ROTATING ELECTRICAL MACHINE | 三菱電機株式会社 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026100508-A1 | RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, SEMICONDUCTOR DEVICE, AND RESIN | 富士フイルム株式会社 | 2026-05-15 | — | — | WO | disclosed |
| EP-3572868-B1 | OPTICAL SHEET FOR LIGHT GUIDE PLATE TYPE LIQUID CRYSTAL DISPLAY, BACKLIGHT UNIT FOR LIGHT GUIDE PLATE TYPE LIQUID CRYSTAL DISPLAY, AND LIGHT GUIDE PLATE TYPE LIQUID CRYSTAL DISPLAY | NITTO DENKO CORP (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20260070874-A1 | BENZOYLFORMIC ACID AMIDE DERIVATIVE | KJ CHEMICALS CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12454631-B2 | Optical laminate with double-sided adhesive layer, and optical device | NITTO DENKO CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| US-20120318854-A1 | THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS INCORPORATING THERMALLY ACTIVATED BASE GENERATORS | PROMERUS LLC (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120318854-A1 | THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS INCORPORATING THERMALLY ACTIVATED BASE GENERATORS | PROMERUS LLC (US) | 2012-12-20 | — | — | US | disclosed |
| CN-1028639-C | Leukotriene antagonist tricyclic derivatives | LILLY CO ELI (US) | 1995-05-31 | — | — | CN | disclosed |
| CN-1054066-A | To reaching the improvement of relevant leukotriene antagonist | LILLY CO ELI (US) | 1991-08-28 | — | — | CN | disclosed |
| US-4455298-A | MOLLUSC EXTRACT | MCFARLANE STUART J (NZ) | 1984-06-19 | — | — | US | disclosed |
| EP-0010061-B1 | PHARMACEUTICAL PREPARATIONS CONTAINING A MOLLUSC EXTRACT | Mc Farlane, Stuart John (NZ) | 1983-07-13 | — | — | EP | disclosed |
| WO-1980000661-A1 | PHARMACEUTICAL PREPARATIONS | CROFT J (NZ) | 1980-04-17 | — | — | WO | disclosed |
| EP-0010061-A1 | Pharmaceutical preparations containing a mollusc extract | Mc Farlane, Stuart John (NZ) | 1980-04-16 | — | — | EP | disclosed |
| EP-0007572-A1 | Pharmaceutical mixtures containing an amantadine compound | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | TTR 3956/4885AKR1B1 2550/4885NPC1 2737/4885 |
| US-12637573-B2 | Antifouling coating composition | COL1A1, COL2A1, HBS1L | TTR 1616/4885AKR1B1 2611/4885NPC1 4199/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | TTR 4118/4885AKR1B1 2018/4885NPC1 4878/4885 |
| US-20260070874-A1 | BENZOYLFORMIC ACID AMIDE DERIVATIVE | CRYAA, BCAT1, BRCA1 | TTR 1664/4885AKR1B1 2037/4885NPC1 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.